Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.6B | 1.5B | 1.6B | 1.5B |
| Cost of revenue | 318.3M | 270.0M | 375.0M | 290.7M |
| Gross profit | 1.3B | 1.2B | 1.3B | 1.2B |
| Operating expense | ||||
| Research & development | 554.0M | 553.2M | 554.8M | 508.9M |
| Selling general and admin | 351.5M | 376.3M | 391.3M | 361.9M |
| Other operating expenses | — | — | — | — |
| Operating income | 376.4M | 251.8M | 310.8M | 360.2M |
| Non operating interest income | ||||
| Income | 89.9M | 55.4M | 35.7M | 41.5M |
| Expense | 94.3M | 10.7M | 15.8M | 11.8M |
| Other income expense | 24.2M | -5.4M | -7.9M | 2.0M |
| Pretax income | 396.2M | 291.1M | 322.9M | 392.0M |
| Tax provision | 47.2M | -6.3M | 62.1M | -30.7M |
| Net income | 345.1M | 297.4M | 1.1B | 404.9M |
| Basic EPS | 2.2 | 1.9 | 7.2 | 2.7 |
| Diluted EPS | 2.2 | 1.9 | 7.1 | 2.6 |
| Basic average shares | 154.9M | 154.4M | 153.9M | 153.4M |
| Diluted average shares | 156.1M | 156.2M | 156.0M | 156.1M |
| EBITDA | 490.7M | 349.7M | 450.7M | 459.7M |
| Net income from continuing op. | 345.1M | 297.4M | 1.1B | 404.9M |
| Minority interests | 222K | -1.7M | 18.5M | 3.2M |
| Preferred stock dividends | — | — | — | — |